A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms of post-traumatic stress disorder, with fewer side effects.

Each newly received vial of a controlled substance, and each substance or mixture (two or more controlled substances combined together such as a Ketamine/Xylazine mixture) used in a procedure must be ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...